ReviewInternational journal of molecular sciences2022

The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer's Disease.

Mingke SongPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.